Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology's Annual Scientific Sess March 30, 2025 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Poste agrees broad terms to buy most of Vivendi's Telecom Italia stake, sources say Back: All Posts Next:Bitcoin (BTC) Bleeds, but Price History Says April Could Be Fire